Indications for treatment (%) | |
---|---|
Primary treatment | 44 (81.4%) |
Pre-surgical devascularization | 5 (9.2%) |
Palliative or symptomatic relief | 5 (9.2%) |
Mean volume of EVOH | 2.2 ml ± 2.3 |
Type of EVOH concentration used (%) | |
18 | 13 (24%) |
34 | 35 (65%) |
Both | 6 (11%) |
Cases with prior embolization and type of agents used (%) | |
No prior treatment | 32 (59.2%) |
Onyx | 9 (16.6%) |
Coils | 5 (9.2%) |
Coils + another agent | 5 (9.2%) |
+ Onyx | 2 |
+ Thrombin | 1 |
+ Gel foam | 1 |
+ Gel foam & Onyx | 1 |
Gel foam | 1 (1.8%) |
Onyx + n-butyl cyanoacrylate (NBCA) | 1 (1.8%) |
Microspheres | 1 (1.8%) |